Abstract
The authors describe primary coronary intervention consisting of direct stenting after abciximab administration in a case of acute anterior myocardial infarction occurring in a heart transplant recipient with triple-vessel disease. Primary success was obtained and the patient survived to a one-year angiographic follow up which showed persistent coronary patency. This is the first report concerning the use of abciximab in primary stenting for acute myocardial infarction in allograft coronary artery disease.
MeSH terms
-
Abciximab
-
Acute Disease
-
Aged
-
Antibodies, Monoclonal / therapeutic use*
-
Anticoagulants / therapeutic use*
-
Coronary Angiography
-
Electrocardiography*
-
Heart Transplantation / adverse effects*
-
Humans
-
Immunoglobulin Fab Fragments / therapeutic use*
-
Male
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / etiology
-
Myocardial Infarction / physiopathology*
-
Myocardial Infarction / therapy*
-
Postoperative Period
-
Stents*
Substances
-
Antibodies, Monoclonal
-
Anticoagulants
-
Immunoglobulin Fab Fragments
-
Abciximab